Home › Metabolic Disorders › Minnesota
Metabolic Disorders clinical trials in Minnesota
3 studies for Metabolic Disorders are looking for participants at sites in Minnesota.
Cities in Minnesota
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
- Mayo Clinic, Rochester
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT06525636A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Minneapolis
- 89bio Clinical Study Site, Rochester
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Maplewood
- 89bio Clinical Study Site, Rochester
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.